Kymera Therapeutics CEO Nello Mainolfi disposes of $3.39 million in common shares
KYMR•CEO Nello Mainolfi exercised options for 30,000 Kymera Therapeutics shares at $2.08 on Oct. 1, 2026, and sold 30,000 shares that day at weighted average prices of $111.44 to $116.12.
1. Share transactions
Mainolfi’s directly held common stock fell to 666,568 shares, while his directly held stock options decreased to 60,000 shares.
